Our top pick for
MKS Instruments Inc is a scientific & technical instruments business based in the US. MKS Instruments shares (MKSI) are listed on the NASDAQ and all prices are listed in US Dollars. MKS Instruments employs 5,400 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$142.90|
|52-week range||$105.42 - $198.90|
|50-day moving average||$147.70|
|200-day moving average||$164.49|
|Wall St. target price||$220.20|
|Dividend yield||$0.82 (0.56%)|
|Earnings per share (TTM)||$8.58|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-21)||-1.71%|
|1 month (2021-09-28)||-5.32%|
|3 months (2021-07-28)||-10.74%|
|6 months (2021-04-28)||-24.06%|
|1 year (2020-10-27)||30.15%|
|2 years (2019-10-25)||28.99%|
|3 years (2018-10-26)||101.89%|
|5 years (2016-10-27)||186.37%|
Valuing MKS Instruments stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MKS Instruments's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MKS Instruments's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, MKS Instruments shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
MKS Instruments's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.61. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MKS Instruments's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MKS Instruments's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $728.1 million.
The EBITDA is a measure of a MKS Instruments's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.7 billion|
|Operating margin TTM||23.49%|
|Gross profit TTM||$1 billion|
|Return on assets TTM||10.09%|
|Return on equity TTM||20.08%|
|Market capitalisation||$8 billion|
TTM: trailing 12 months
There are currently 1.2 million MKS Instruments shares held short by investors – that's known as MKS Instruments's "short interest". This figure is 11.8% down from 1.4 million last month.
There are a few different ways that this level of interest in shorting MKS Instruments shares can be evaluated.
MKS Instruments's "short interest ratio" (SIR) is the quantity of MKS Instruments shares currently shorted divided by the average quantity of MKS Instruments shares traded daily (recently around 406963.78737542). MKS Instruments's SIR currently stands at 3.01. In other words for every 100,000 MKS Instruments shares traded daily on the market, roughly 3010 shares are currently held short.
However MKS Instruments's short interest can also be evaluated against the total number of MKS Instruments shares, or, against the total number of tradable MKS Instruments shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MKS Instruments's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 MKS Instruments shares in existence, roughly 20 shares are currently held short) or 0.0222% of the tradable shares (for every 100,000 tradable MKS Instruments shares, roughly 22 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against MKS Instruments.
Find out more about how you can short MKS Instruments stock.
Dividend payout ratio: 8.53% of net profits
Recently MKS Instruments has paid out, on average, around 8.53% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.61% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), MKS Instruments shareholders could enjoy a 0.61% return on their shares, in the form of dividend payments. In MKS Instruments's case, that would currently equate to about $0.82 per share.
While MKS Instruments's payout ratio might seem low, this can signify that MKS Instruments is investing more in its future growth.
MKS Instruments's most recent dividend payout was on 9 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 26 August 2021 (the "ex-dividend date").
Over the last 12 months, MKS Instruments's shares have ranged in value from as little as $105.423 up to $198.9007. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MKS Instruments's is 1.481. This would suggest that MKS Instruments's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes worldwide. Its Vacuum & Analysis segment offers pressure and vacuum control solutions, including direct and indirect pressure measurement; materials delivery solutions comprising flow and valve technologies, as well as integrated pressure measurement and control subsystems, which provide customers with precise control capabilities; power delivery products, such as microwave, power delivery systems, radio frequency matching networks, and metrology products used in providing energy to etching, stripping, and deposition processes; and plasma and reactive gas products. The company's Light & Motion segment offers laser-based systems, such as amplifiers, fiber lasers, diode-pumped solid-state lasers, high-energy pulsed lasers, and tunable lasers; and photonics products comprising optical components, lens assemblies, and vibration isolation solutions, as well as instruments and motion products, such as high-precision motion stages and controls, hexapods, photonics instruments for measurement and analysis, and production equipment for test and measurement. Its Equipment & Solutions segment provides laser-based systems for printed circuit board (PCB) manufacturing, including flexible interconnect PCB processing systems and high-density interconnect solutions for rigid PCB manufacturing and substrate processing, as well as passive component multilayer ceramic capacitor testing. The company serves semiconductor, industrial technologies, life and health sciences, research, and defense markets. It markets and sells its products and services through its direct sales organization, independent distributors, and sales representatives, as well as through its websites and product catalogs.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.